Kingsview Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $9.45M | Buy |
23,295
+1,760
| +8% | +$714K | 0.16% | 122 |
|
2025
Q1 | $10.7M | Buy |
21,535
+1,238
| +6% | +$616K | 0.2% | 105 |
|
2024
Q4 | $10.6M | Buy |
20,297
+1,694
| +9% | +$881K | 0.21% | 94 |
|
2024
Q3 | $11.5M | Sell |
18,603
-62
| -0.3% | -$38.4K | 0.24% | 75 |
|
2024
Q2 | $10.3M | Buy |
18,665
+533
| +3% | +$295K | 0.24% | 79 |
|
2024
Q1 | $10.5M | Buy |
18,132
+1,128
| +7% | +$656K | 0.26% | 77 |
|
2023
Q4 | $9.03M | Buy |
17,004
+1,591
| +10% | +$844K | 0.27% | 82 |
|
2023
Q3 | $7.8M | Buy |
15,413
+440
| +3% | +$223K | 0.28% | 80 |
|
2023
Q2 | $7.81M | Sell |
14,973
-1,363
| -8% | -$711K | 0.31% | 74 |
|
2023
Q1 | $9.42M | Buy |
16,336
+3,975
| +32% | +$2.29M | 0.4% | 56 |
|
2022
Q4 | $6.81M | Sell |
12,361
-15,690
| -56% | -$8.64M | 0.3% | 86 |
|
2022
Q3 | $14.2M | Buy |
28,051
+10,843
| +63% | +$5.5M | 0.67% | 24 |
|
2022
Q2 | $9.35M | Buy |
17,208
+1,055
| +7% | +$573K | 0.45% | 46 |
|
2022
Q1 | $9.54M | Sell |
16,153
-1,117
| -6% | -$660K | 0.42% | 50 |
|
2021
Q4 | $11.5M | Buy |
17,270
+539
| +3% | +$360K | 0.48% | 39 |
|
2021
Q3 | $9.56M | Buy |
16,731
+662
| +4% | +$378K | 0.45% | 40 |
|
2021
Q2 | $8.19M | Buy |
16,069
+3,047
| +23% | +$1.55M | 0.4% | 45 |
|
2021
Q1 | $5.94M | Buy |
13,022
+5,068
| +64% | +$2.31M | 0.34% | 67 |
|
2020
Q4 | $3.71M | Buy |
7,954
+3,552
| +81% | +$1.65M | 0.27% | 90 |
|
2020
Q3 | $1.94M | Buy |
4,402
+10
| +0.2% | +$4.42K | 0.17% | 139 |
|
2020
Q2 | $1.59M | Buy |
4,392
+623
| +17% | +$226K | 0.16% | 144 |
|
2020
Q1 | $1.07M | Buy |
3,769
+912
| +32% | +$259K | 0.14% | 169 |
|
2019
Q4 | $928K | Buy |
2,857
+1,056
| +59% | +$343K | 0.12% | 203 |
|
2019
Q3 | $525K | Sell |
1,801
-246
| -12% | -$71.7K | 0.08% | 245 |
|
2019
Q2 | $601K | Sell |
2,047
-1,320
| -39% | -$388K | 0.1% | 217 |
|
2019
Q1 | $922K | Sell |
3,367
-70
| -2% | -$19.2K | 0.14% | 189 |
|
2018
Q4 | $769K | Sell |
3,437
-150
| -4% | -$33.6K | 0.17% | 164 |
|
2018
Q3 | $875K | Buy |
3,587
+559
| +18% | +$136K | 0.18% | 160 |
|
2018
Q2 | $627K | Buy |
3,028
+242
| +9% | +$50.1K | 0.15% | 167 |
|
2018
Q1 | $575K | Buy |
2,786
+671
| +32% | +$138K | 0.14% | 184 |
|
2017
Q4 | $402K | Buy |
2,115
+261
| +14% | +$49.6K | 0.14% | 199 |
|
2017
Q3 | $351K | Buy |
1,854
+24
| +1% | +$4.54K | 0.15% | 188 |
|
2017
Q2 | $319K | Buy |
1,830
+51
| +3% | +$8.89K | 0.16% | 174 |
|
2017
Q1 | $273K | Buy |
+1,779
| New | +$273K | 0.16% | 188 |
|